gadolinium has been researched along with Pulmonary Arterial Hypertension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Błaszczak, P; Hładuński, M; Kamiński, K; Kazimierczyk, R; Małek, Ł; Myśliwiec, J; Nekolla, S; Sobkowicz, B; Szumowski, P; Tarasiuk, E | 1 |
| Błaszczak, P; Grzywna, R; Hładuński, M; Jurgilewicz, D; Kamiński, KA; Kazimierczyk, R; Małek, ŁA; Musiał, WJ; Myśliwiec, J; Sobkowicz, B; Szumowski, P | 1 |
2 other study(ies) available for gadolinium and Pulmonary Arterial Hypertension
| Article | Year |
|---|---|
Platelet sTWEAK and plasma IL-6 are associated with 18F-fluorodeoxyglucose uptake in right ventricles of patients with pulmonary arterial hypertension: A pilot study.
Topics: Clinical Deterioration; Contrast Media; Fluorodeoxyglucose F18; Gadolinium; Heart Ventricles; Humans; Hypertension, Pulmonary; Interleukin-6; Pilot Projects; Pulmonary Arterial Hypertension; Tumor Necrosis Factors | 2022 |
Prognostic value of late gadolinium enhancement mass index in patients with pulmonary arterial hypertension.
Topics: Case-Control Studies; Contrast Media; Female; Follow-Up Studies; Gadolinium; Hemodynamics; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prognosis; Pulmonary Arterial Hypertension; Survival Rate; Ventricular Dysfunction, Right | 2021 |